Abstract
Children with nonalcoholic fatty liver disease (NAFLD) display an altered gut microbiota compared with healthy children. However, little is known about the fecal bile acid profiles and their association with gut microbiota dysbiosis in pediatric NAFLD. A total of 68 children were enrolled in this study, including 32 NAFLD patients and 36 healthy children. Fecal samples were collected and analyzed by metagenomic sequencing to determine the changes in the gut microbiota of children with NAFLD, and an ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) system was used to quantify the concentrations of primary and secondary bile acids. The associations between the gut microbiota and concentrations of primary and secondary bile acids in the fecal samples were then analyzed. We found that children with NAFLD exhibited reduced levels of secondary bile acids and alterations in bile acid biotransforming-related bacteria in the feces. Notably, the decrease in Eubacterium and Ruminococcaceae bacteria, which express bile salt hydrolase and 7α-dehydroxylase, was significantly positively correlated with the level of fecal lithocholic acid (LCA). However, the level of fecal LCA was negatively associated with the abundance of the potential pathogen Escherichia coli that was enriched in children with NAFLD. Pediatric NAFLD is characterized by an altered profile of gut microbiota and fecal bile acids. This study demonstrates that the disease-associated gut microbiota is linked with decreased concentrations of secondary bile acids in the feces. The disease-associated gut microbiota likely inhibits the conversion of primary to secondary bile acids.
Introduction
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver condition in children worldwide, yet its pathogenesis remains partially obscured. While researchers have long suspected the "gut-liver axis" plays a role, the specific metabolic dialogue between gut bacteria and the host is still being decoded.
Bile acids (BAs) are central to this dialogue. Beyond their role in fat digestion, BAs act as signaling molecules that bind to receptors like TGR5 and FXR to regulate systemic metabolism. Gut bacteria are responsible for "biotransforming" primary BAs (produced by the liver) into secondary BAs. This study addresses a critical gap: how does gut dysbiosis in pediatric NAFLD specifically alter the fecal bile acid profile and the bacterial enzymes responsible for these transformations?
Methods
The researchers conducted a cross-sectional study of 68 children (32 with NAFLD and 36 healthy controls). They employed a multi-omics approach:
- Metagenomic Shotgun Sequencing: This provided a deep look at the species-level composition and the functional gene potential of the gut microbiome.
- Targeted Metabolomics (UPLC-MS/MS): Ultra-performance liquid chromatography coupled to tandem mass spectrometry was used to precisely quantify 42 different bile acids in fecal samples.
- Bioinformatics: LEfSe (Linear Discriminant Analysis Effect Size) identified microbial biomarkers, and the KEGG database was used to predict the abundance of specific bile-metabolizing enzymes, such as bile salt hydrolase (BSH) and 7α-dehydroxylase.
Results and Discussion
Microbial Dysbiosis in Pediatric NAFLD
Analysis of the gut microbiota revealed significant differences between children with NAFLD (NG) and healthy controls (HC). PCoA analysis demonstrated a clear separation in microbial community structure between the two groups. At the phylum level, while the overall composition remained dominated by Firmicutes and Bacteroidetes, specific shifts were evident in the relative abundance of several taxa.
Further investigation using LEfSe identified specific microbial biomarkers. NAFLD patients showed a significant enrichment of potential pathogens, including Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae. Conversely, healthy children were enriched with protective species such as Akkermansia muciniphila, Alistipes putredinis, and various members of the Bacteroides and Eubacterium genera.
Altered Bile Acid Profiles and Functional Impairment
The metabolic profile of fecal bile acids was markedly different in the NAFLD group. Secondary BAs accounted for only 57.16% of the total BA pool in NAFLD children, compared to 74.40% in healthy controls. Several specific secondary BAs, including lithocholic acid (LCA), hyodeoxycholic acid (HDCA), and 7-ketolithocholic acid (7-KetoLCA), were significantly lower in the NAFLD group.
The study found a significant decrease in the predicted abundance of the BSH gene (K01442) in NAFLD patients, suggesting the microbiome is functionally less capable of initiating bile acid metabolism. The reduction in secondary BAs like LCA is particularly concerning because these molecules are potent activators of the TGR5 receptor, which typically improves insulin sensitivity and reduces hepatic inflammation.
Interestingly, LCA levels were negatively correlated with the abundance of Escherichia coli. Since LCA has known antibacterial properties, its reduction may create a permissive environment for pathogens like E. coli to bloom, further exacerbating the disease state.
Conclusion
This study demonstrates that pediatric NAFLD is characterized by a "disease-associated" gut microbiota that is functionally impaired in its ability to convert primary bile acids into secondary bile acids. This metabolic shift results in significantly lower levels of fecal secondary bile acids, potentially depriving the host of critical signaling molecules. While this cross-sectional study cannot definitively prove causality, it highlights the importance of the gut-liver-bile acid axis in NAFLD and suggests that restoring specific bacterial species or secondary BA levels could be a potential therapeutic strategy.
Summary updated